Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Harvard Catalyst offices will be closed for winter recess December 22 - January 1.
Keywords
Last Name
Institution

profileAnkur Pandya, Ph.D.

TitleAssistant Professor of Health Decision Science
InstitutionHarvard T.H. Chan School of Public Health
DepartmentHealth Policy and Management
AddressHarvard School of Public Health
2nd Floor
718 Huntington Ave
Boston MA 02115
vCardDownload vCard (login for email)

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Menzies NA, Soeteman DI, Pandya A, Kim JJ. Bayesian Methods for Calibrating Health Policy Models: A Tutorial. Pharmacoeconomics. 2017 Jun; 35(6):613-624. PMID: 28247184.
    View in: PubMed
  2. Soliman F, Gupta A, Delgado D, Kamel H, Pandya A. The Role of Imaging in Clinical Stroke Scales That Predict Functional Outcome: A Systematic Review. Neurohospitalist. 2017 Oct; 7(4):169-178. PMID: 28974995.
    View in: PubMed
  3. Pandya A, Sy S, Cho S, Alam S, Weinstein MC, Gaziano TA. Validation of a Cardiovascular Disease Policy Microsimulation Model Using Both Survival and Receiver Operating Characteristic Curves. Med Decis Making. 2017 Oct; 37(7):802-814. PMID: 28490271.
    View in: PubMed
  4. Reznik M, Kamel H, Gialdini G, Pandya A, Navi BB, Gupta A. Timing of Carotid Revascularization Procedures After Ischemic Stroke. Stroke. 2017 Jan; 48(1):225-228. PMID: 27924050.
    View in: PubMed
  5. Chu P, Pandya A, Salomon JA, Goldie SJ, Hunink MG. Comparative Effectiveness of Personalized Lifestyle Management Strategies for Cardiovascular Disease Risk Reduction. J Am Heart Assoc. 2016 Mar 29; 5(3):e002737. PMID: 27025969; PMCID: PMC4943251.
  6. Gaziano TA, Abrahams-Gessel S, Alam S, Alam D, Ali M, Bloomfield G, Carrillo-Larco RM, Dorairaj P, Gutierrez L, Irazola V, Levitt NS, Miranda JJ, Bernabe-Ortiz A, Pandya A, Rubinstein A, Steyn K, Xavier D, Yan LL. Comparison of Nonblood-Based and Blood-Based Total CV Risk Scores in Global Populations. Glob Heart. 2016 Mar; 11(1):37-46.e2. PMID: 27102021.
    View in: PubMed
  7. Gupta A, Giambrone AE, Gialdini G, Finn C, Delgado D, Gutierrez J, Wright C, Beiser AS, Seshadri S, Pandya A, Kamel H. Silent Brain Infarction and Risk of Future Stroke: A Systematic Review and Meta-Analysis. Stroke. 2016 Mar; 47(3):719-25. PMID: 26888534; PMCID: PMC4766016 [Available on 03/01/17].
  8. Pandya A, Eggman AA, Kamel H, Gupta A, Schackman BR, Sanelli PC. Modeling the Cost Effectiveness of Neuroimaging-Based Treatment of Acute Wake-Up Stroke. PLoS One. 2016; 11(2):e0148106. PMID: 26840397; PMCID: PMC4740488.
  9. Gupta A, Mushlin AI, Kamel H, Navi BB, Pandya A. Cost-Effectiveness of Carotid Plaque MR Imaging as a Stroke Risk Stratification Tool in Asymptomatic Carotid Artery Stenosis. Radiology. 2015 Dec; 277(3):927. PMID: 26599936.
    View in: PubMed
  10. Pandya A, Weinstein MC, Gaziano TA. Cost-effectiveness of Statin Therapy for ASCVD--Reply. JAMA. 2015 Nov 24; 314(20):2191-2. PMID: 26599190.
    View in: PubMed
  11. Gaziano T, Abrahams-Gessel S, Surka S, Sy S, Pandya A, Denman CA, Mendoza C, Puoane T, Levitt NS. Cardiovascular Disease Screening By Community Health Workers Can Be Cost-Effective In Low-Resource Countries. Health Aff (Millwood). 2015 Sep; 34(9):1538-45. PMID: 26355056; PMCID: PMC4795815.
  12. Gaziano T, Cho S, Sy S, Pandya A, Levitt NS, Steyn K. Increasing Prescription Length Could Cut Cardiovascular Disease Burden And Produce Savings In South Africa. Health Aff (Millwood). 2015 Sep; 34(9):1578-85. PMID: 26355061; PMCID: PMC4816639.
  13. Pandya A, Gupta A. Improving imaging to optimize screening strategies for carotid artery stenosis. Clin Imaging. 2016 Mar-Apr; 40(2):276-8. PMID: 26275846.
    View in: PubMed
  14. Pandya A, Sy S, Cho S, Weinstein MC, Gaziano TA. Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease. JAMA. 2015 Jul 14; 314(2):142-50. PMID: 26172894; PMCID: PMC4797634.
  15. Gupta A, Mushlin AI, Kamel H, Navi BB, Pandya A. Cost-Effectiveness of Carotid Plaque MR Imaging as a Stroke Risk Stratification Tool in Asymptomatic Carotid Artery Stenosis. Radiology. 2015 Dec; 277(3):763-72. PMID: 26098459.
    View in: PubMed
  16. Gupta A, Baradaran H, Mtui EE, Kamel H, Pandya A, Giambrone A, Iadecola C, Sanelli PC. Detection of Symptomatic Carotid Plaque Using Source Data from MR and CT Angiography: A Correlative Study. Cerebrovasc Dis. 2015; 39(3-4):151-61. PMID: 25721945; PMCID: PMC4737480.
  17. Sullivan CL, Pandya A, Min RJ, Drotman M, Hentel K. The development and implementation of a patient-centered radiology consultation service: a focus on breast density and additional screening options. Clin Imaging. 2015 Sep-Oct; 39(5):731-4. PMID: 25655643.
    View in: PubMed
  18. Gupta A, Kesavabhotla K, Baradaran H, Kamel H, Pandya A, Giambrone AE, Wright D, Pain KJ, Mtui EE, Suri JS, Sanelli PC, Mushlin AI. Plaque echolucency and stroke risk in asymptomatic carotid stenosis: a systematic review and meta-analysis. Stroke. 2015 Jan; 46(1):91-7. PMID: 25406150; PMCID: PMC4280234 [Available on 01/01/16].
  19. Pandya A, Gupta A, Kamel H, Navi BB, Sanelli PC, Schackman BR. Carotid artery stenosis: cost-effectiveness of assessment of cerebrovascular reserve to guide treatment of asymptomatic patients. Radiology. 2015 Feb; 274(2):455-63. PMID: 25225841; PMCID: PMC4334157.
  20. DeaƱo RC, Pandya A, Jones EC, Borden WB. A look at statin cost-effectiveness in view of the 2013 ACC/AHA cholesterol management guidelines. Curr Atheroscler Rep. 2014 Sep; 16(9):438. PMID: 25052768.
    View in: PubMed
  21. Gupta A, Baradaran H, Kamel H, Pandya A, Mangla A, Dunning A, Marshall RS, Sanelli PC. Evaluation of computed tomography angiography plaque thickness measurements in high-grade carotid artery stenosis. Stroke. 2014 Mar; 45(3):740-5. PMID: 24496392.
    View in: PubMed
  22. Pandya A, Weinstein MC, Salomon JA, Cutler D, Gaziano TA. Who needs laboratories and who needs statins?: comparative and cost-effectiveness analyses of non-laboratory-based, laboratory-based, and staged primary cardiovascular disease screening guidelines. Circ Cardiovasc Qual Outcomes. 2014 Jan; 7(1):25-32. PMID: 24425701; PMCID: PMC3971865.
  23. Simon MS, Leff JA, Pandya A, Cushing M, Shaz BH, Calfee DP, Schackman BR, Mushlin AI. Cost-effectiveness of blood donor screening for Babesia microti in endemic regions of the United States. Transfusion. 2014 Mar; 54(3 Pt 2):889-99. PMID: 24252132; PMCID: PMC4039174.
  24. Pandya A, Gaziano TA, Weinstein MC, Cutler D. More americans living longer with cardiovascular disease will increase costs while lowering quality of life. Health Aff (Millwood). 2013 Oct; 32(10):1706-14. PMID: 24101059; PMCID: PMC3894660.
  25. Gupta A, Baradaran H, Schweitzer AD, Kamel H, Pandya A, Delgado D, Dunning A, Mushlin AI, Sanelli PC. Carotid plaque MRI and stroke risk: a systematic review and meta-analysis. Stroke. 2013 Nov; 44(11):3071-7. PMID: 23988640.
    View in: PubMed
  26. Gaziano TA, Pandya A, Steyn K, Levitt N, Mollentze W, Joubert G, Walsh CM, Motala AA, Kruger A, Schutte AE, Naidoo DP, Prakaschandra DR, Laubscher R. Comparative assessment of absolute cardiovascular disease risk characterization from non-laboratory-based risk assessment in South African populations. BMC Med. 2013 Jul 24; 11:170. PMID: 23880010; PMCID: PMC3734109.
  27. Kim FS, Tran HH, Sinha I, Patel A, Nelson RA, Pandya AN, Keswani S, Watkins JF. Experience with corrective surgery for postburn contractures in Mumbai, India. J Burn Care Res. 2012 May-Jun; 33(3):e120-6. PMID: 22210060.
    View in: PubMed
  28. O'Sullivan AK, Weinstein MC, Pandya A, Thompson D, Langston AA, Perfect JR, Papadopoulos G. Cost-effectiveness of posaconazole versus fluconazole for prevention of invasive fungal infections in U.S. patients with graft-versus-host disease. Am J Health Syst Pharm. 2012 Jan 15; 69(2):149-56. PMID: 22215361.
    View in: PubMed
  29. McGlone ER, Goutos I, Nelson RA, Pandya A. Primus stove burns: a persisting problem in developing countries. Int J Burns Trauma. 2011; 1(1):11-6. PMID: 22928153; PMCID: PMC3415938.
  30. Goutos I, Jennings CL, Pandya A. Reconstruction of the burnt perionychium: literature review and treatment algorithm. J Burn Care Res. 2011 Jul-Aug; 32(4):451-7. PMID: 21646914.
    View in: PubMed
  31. Pandya A, Weinstein MC, Gaziano TA. A comparative assessment of non-laboratory-based versus commonly used laboratory-based cardiovascular disease risk scores in the NHANES III population. PLoS One. 2011; 6(5):e20416. PMID: 21655241; PMCID: PMC3105026.
  32. Taylor DC, Pawar V, Kruzikas D, Gilmore KE, Pandya A, Iskandar R, Weinstein MC. Calibrating longitudinal models to cross-sectional data: the effect of temporal changes in health practices. Value Health. 2011 Jul-Aug; 14(5):700-4. PMID: 21839408.
    View in: PubMed
  33. Rosen VM, Taylor DC, Parekh H, Pandya A, Thompson D, Kuznik A, Waters DD, Drummond M, Weinstein MC. Cost effectiveness of intensive lipid-lowering treatment for patients with congestive heart failure and coronary heart disease in the US. Pharmacoeconomics. 2010; 28(1):47-60. PMID: 20014876.
    View in: PubMed
  34. Taylor DC, Pawar V, Kruzikas D, Gilmore KE, Pandya A, Iskandar R, Weinstein MC. Methods of model calibration: observations from a mathematical model of cervical cancer. Pharmacoeconomics. 2010; 28(11):995-1000. PMID: 20936883.
    View in: PubMed
  35. O'Sullivan AK, Pandya A, Papadopoulos G, Thompson D, Langston A, Perfect J, Weinstein MC. Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among neutropenic patients in the United States. Value Health. 2009 Jul-Aug; 12(5):666-73. PMID: 19508661.
    View in: PubMed
  36. Wagner M, Goetghebeur M, Merikle E, Pandya A, Chu P, Taylor DC. Cost-effectiveness of intensive lipid lowering therapy with 80 mg of atorvastatin, versus 10 mg of atorvastatin, for secondary prevention of cardiovascular disease in Canada. Can J Clin Pharmacol. 2009; 16(2):e331-45. PMID: 19531812.
    View in: PubMed
  37. Taylor DC, Pandya A, Thompson D, Chu P, Graff J, Shepherd J, Wenger N, Greten H, Carmena R, Drummond M, Weinstein MC. Cost-effectiveness of intensive atorvastatin therapy in secondary cardiovascular prevention in the United Kingdom, Spain, and Germany, based on the Treating to New Targets study. Eur J Health Econ. 2009 Jul; 10(3):255-65. PMID: 18800232.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu).
Pandya's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description